Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference
Rhea-AI Summary
Prestige Consumer Healthcare (NYSE: PBH) will release its fiscal 2026 third quarter earnings on Thursday, February 5, 2026 before market open and will host a conference call the same morning at 8:30 a.m. ET.
Investors can join a live Internet webcast or register for phone access to receive dial-in details and a unique PIN; joining 10 minutes early is recommended. A conference call replay will be available for approximately one week on the company’s Investor Relations page.
Separately, the company will participate in a fireside chat at the 28th Annual ICR Conference on Tuesday, January 13, 2026 at 9:30 a.m. ET, with a live audio webcast and a replay available later that day.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, PBH gained 1.76%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peer moves appear mixed: PRGO up 1.89%, AMRX down 1.76%, INDV down 0.23%, while HCM and LNTH were flat. Momentum scanner only flagged ANIP with a 10.62% upside move and no news, suggesting today’s PBH setup is stock-specific rather than a coordinated sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 06 | Q2 earnings results | Positive | +2.6% | Q2 revenue ahead of outlook and raised EPS guidance supported a modest gain. |
| Oct 06 | Q2 earnings date | Neutral | -0.5% | Scheduling of Q2 and first-half results call produced only a slight price move. |
| Sep 04 | Conference appearance | Neutral | -0.2% | Barclays conference participation announcement coincided with a minor share decline. |
| Aug 07 | Q1 earnings results | Negative | -10.1% | Revenue decline and lowered fiscal 2026 guidance drove a double-digit drop. |
| Jul 15 | Q1 earnings date | Neutral | -1.7% | Announcement of Q1 earnings release and call saw a modest negative reaction. |
Price reactions have generally aligned with news tone: fundamental results (Q1, Q2) drew larger directional moves, while simple scheduling and conference notices saw modest, often negative, drift.
Over the past months, PBH has reported fiscal 2026 results and multiple event schedules. Q1 revenue was $249.5M with guidance reduced, prompting a -10.05% move. Q2 revenue of $274.1M, ahead of outlook with raised EPS guidance to $4.54–$4.58, saw shares gain 2.56%. Other releases, such as earnings date announcements on Aug 7, 2025 and Nov 6, 2025, and a Barclays conference appearance, produced small negative moves. Today’s notice of the Q3 earnings date and ICR fireside chat fits this pattern of scheduling-focused communications.
Market Pulse Summary
This announcement sets clear timing for PBH’s fiscal 2026 Q3 earnings release on February 5, 2026 and highlights additional visibility via a fireside chat at the 28th Annual ICR Conference on January 13, 2026. Recent history shows that pure scheduling items have had limited directional impact, while actual Q1 and Q2 results drove larger moves. Investors may focus on how upcoming results relate to prior guidance changes and recent regulatory filings, including ownership disclosures and insider sales.
AI-generated analysis. Not financial advice.
TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings release on Thursday, February 5, 2026 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
ICR Conference
Separately, the company will also participate in a fireside chat at the 28th Annual ICR Conference on Tuesday, January 13, 2026 at 9:30 a.m. ET. Interested parties may access a live audio webcast of this event from the Investor Relations page of www.prestigeconsumerhealthcare.com. A replay of the webcast will be available later that same day.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Source: Prestige Consumer Healthcare Inc.

Investor Relations Contact Phil Terpolilli, CFA, 914-524-6819 irinquiries@prestigebrands.com